Imaging of Neuroendocrine Prostatic Carcinoma

Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer that typically has a high metastatic potential and poor prognosis in comparison to the adenocarcinoma subtype. Although it can arise de novo, NEPC much more commonly occurs as a mechanism of treatment resistance during...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ahmed Taher, Corey T. Jensen, Sireesha Yedururi, Devaki Shilpa Surasi, Silvana C. Faria, Tharakeshwar K. Bathala, Bilal Mujtaba, Priya Bhosale, Nicolaus Wagner-Bartak, Ajaykumar C. Morani
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	prostate neuroendocrine prostatic neuroendocrine carcinoma small cell carcinoma of prostate Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/dd1261b0900845e2855ab4961515fcea
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:dd1261b0900845e2855ab4961515fcea
record_format	dspace
spelling	oai:doaj.org-article:dd1261b0900845e2855ab4961515fcea2021-11-25T17:03:45ZImaging of Neuroendocrine Prostatic Carcinoma10.3390/cancers132257652072-6694https://doaj.org/article/dd1261b0900845e2855ab4961515fcea2021-11-01T00:00:00Zhttps://www.mdpi.com/2072-6694/13/22/5765https://doaj.org/toc/2072-6694Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer that typically has a high metastatic potential and poor prognosis in comparison to the adenocarcinoma subtype. Although it can arise de novo, NEPC much more commonly occurs as a mechanism of treatment resistance during therapy for conventional prostatic adenocarcinoma, the latter is also termed as castration-resistant prostate cancer (CRPC). The incidence of NEPC increases after hormonal therapy and they represent a challenge, both in the radiological and pathological diagnosis, as well as in the clinical management. This article provides a comprehensive imaging review of prostatic neuroendocrine tumors.Ahmed TaherCorey T. JensenSireesha YedururiDevaki Shilpa SurasiSilvana C. FariaTharakeshwar K. BathalaBilal MujtabaPriya BhosaleNicolaus Wagner-BartakAjaykumar C. MoraniMDPI AGarticleprostateneuroendocrineprostatic neuroendocrine carcinomasmall cell carcinoma of prostateNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENCancers, Vol 13, Iss 5765, p 5765 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	prostate neuroendocrine prostatic neuroendocrine carcinoma small cell carcinoma of prostate Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	prostate neuroendocrine prostatic neuroendocrine carcinoma small cell carcinoma of prostate Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Ahmed Taher Corey T. Jensen Sireesha Yedururi Devaki Shilpa Surasi Silvana C. Faria Tharakeshwar K. Bathala Bilal Mujtaba Priya Bhosale Nicolaus Wagner-Bartak Ajaykumar C. Morani Imaging of Neuroendocrine Prostatic Carcinoma
description	Neuroendocrine prostate cancer (NEPC) is an aggressive subtype of prostate cancer that typically has a high metastatic potential and poor prognosis in comparison to the adenocarcinoma subtype. Although it can arise de novo, NEPC much more commonly occurs as a mechanism of treatment resistance during therapy for conventional prostatic adenocarcinoma, the latter is also termed as castration-resistant prostate cancer (CRPC). The incidence of NEPC increases after hormonal therapy and they represent a challenge, both in the radiological and pathological diagnosis, as well as in the clinical management. This article provides a comprehensive imaging review of prostatic neuroendocrine tumors.
format	article
author	Ahmed Taher Corey T. Jensen Sireesha Yedururi Devaki Shilpa Surasi Silvana C. Faria Tharakeshwar K. Bathala Bilal Mujtaba Priya Bhosale Nicolaus Wagner-Bartak Ajaykumar C. Morani
author_facet	Ahmed Taher Corey T. Jensen Sireesha Yedururi Devaki Shilpa Surasi Silvana C. Faria Tharakeshwar K. Bathala Bilal Mujtaba Priya Bhosale Nicolaus Wagner-Bartak Ajaykumar C. Morani
author_sort	Ahmed Taher
title	Imaging of Neuroendocrine Prostatic Carcinoma
title_short	Imaging of Neuroendocrine Prostatic Carcinoma
title_full	Imaging of Neuroendocrine Prostatic Carcinoma
title_fullStr	Imaging of Neuroendocrine Prostatic Carcinoma
title_full_unstemmed	Imaging of Neuroendocrine Prostatic Carcinoma
title_sort	imaging of neuroendocrine prostatic carcinoma
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/dd1261b0900845e2855ab4961515fcea
work_keys_str_mv	AT ahmedtaher imagingofneuroendocrineprostaticcarcinoma AT coreytjensen imagingofneuroendocrineprostaticcarcinoma AT sireeshayedururi imagingofneuroendocrineprostaticcarcinoma AT devakishilpasurasi imagingofneuroendocrineprostaticcarcinoma AT silvanacfaria imagingofneuroendocrineprostaticcarcinoma AT tharakeshwarkbathala imagingofneuroendocrineprostaticcarcinoma AT bilalmujtaba imagingofneuroendocrineprostaticcarcinoma AT priyabhosale imagingofneuroendocrineprostaticcarcinoma AT nicolauswagnerbartak imagingofneuroendocrineprostaticcarcinoma AT ajaykumarcmorani imagingofneuroendocrineprostaticcarcinoma
_version_	1718412808165523456

Imaging of Neuroendocrine Prostatic Carcinoma

Ejemplares similares